FFAR2 and colitis: To investigate the possible synergistic anti-inflammatory effect of a MOR agonist DAMGO and a FFAR2 antagonist GLPG 0974 in the mouse GI tract, we used a well-known mouse model of colitis induced by DSS which mimics UC.